↓ Skip to main content

Prolonged COVID-19 in an Immunocompromised Patient Treated with Obinutuzumab and Bendamustine for Follicular Lymphoma

Overview of attention for article published in Internal Medicine, May 2022
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (70th percentile)
  • High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

twitter
6 X users

Citations

dimensions_citation
12 Dimensions

Readers on

mendeley
21 Mendeley